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Abstract: Ultrasound hyperthermia is a medical treatment used to increase temperature of tissues.
It can be used independently or as a supportive method for an anticancer treatment. The therapeutic
efficacy of focused ultrasound hyperthermia can be improved using sonosensitizers, nanoparticles
enhancing the attenuation and dissipation of acoustic energy. As sonosensitizers, we propose
magnetic nanoparticles owing to their biodegradability, biocompatibility, and simple positioning
in tissues using a magnetic field. Focused ultrasound hyperthermia studies were performed using
tissue-mimicking phantoms. Temperature changes were measured at various ultrasound powers and
distances from the center of the ultrasound focus. Specific absorption rate (SAR) values, describing
the power deposition in the tissues during the hyperthermia treatment, were evaluated for the center
of the focus point and for various distances from it. The results show that the addition of nanoparticles
increases the SAR almost two times compared to that for the pure phantom. The highest SAR is
obtained in the ultrasound focus; it decreases with the increase of the distance from the focus.
Keywords: focused ultrasound; therapeutic ultrasound; ultrasound hyperthermia; magnetic
nanoparticles; sonosensitizers
1. Introduction
The clinical ultrasounds are acoustic waves with frequencies in the range of 1–10 MHz. Owing to
their small wavelength on the order of millimeters, as well as the possibility to focus their beam in
a small area, they have been employed in various biomedical applications [1–3]. Most commonly,
ultrasounds are used in diagnostic medical imaging, referred to as ultrasonography and ultrasound
tomography [3–7]. They are also very important in enhanced drug uptake through skin, i.e.,
sonophoresis, transdermal drug delivery, and lithotripsy to destroy kidney stones [2,3]. Furthermore,
they have been employed in various thermal therapies. Depending on the temperature increase
induced by the ultrasound waves, a few thermal therapies can be distinguished [2,8].
Hyperthermia is a medical treatment involving an increase of the tissue temperature to
42–45 ◦C [4,9,10]. It is commonly used for noninvasive heating of muscles and tendons [2].
Numerous biological and clinical investigations have demonstrated that hyperthermia is a very
promising anticancer medical treatment. The heat generated in the cancer tissue leads to its
weakening. The weakened cells are more susceptible to other cancer treatments such as radiotherapy
or chemotherapy [8]. The medical procedure in which the temperature is increased to values above
45 ◦C is referred to as thermal ablation. It causes irreversible changes in tissues and direct destruction
of cancer cells [8,9,11].
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The most important advantage of ultrasound heating, compared to other external stimuli, is that
the acoustic beam can be focused and localized with a millimeter precision. Therefore, it precisely
interacts with a small volume of the tissue. The energy of the focused ultrasound (FUS) can be
deposited in a lesion with a diameter of 1 mm [12]. This beam focusing ability minimizes the
possibility of thermal damage of tissues localized near the focal area or between the focal point and
transducer [5,13,14]. FUS is widely used in medicine for therapeutic purposes [3,5,14]. Depending on
the energy values, FUS can be used for ablation, cell destruction, necrosis, or cell apoptosis [3,5,14].
High-temperature FUS provides a precise targeted drug delivery and targeted drug release in a local
area [2,4]. In contrast to other therapies, e.g., cryoablation, the FUS therapy is noninvasive and reaches
tissues and areas localized deep within the body [14]. By appropriate choice of frequency penetration
depth of ultrasound in tissue can be controlled [15]. Higher frequencies produce concentrated absorbed
energy but fall off quickly with depth. Lower frequencies, conversely, are not quickly absorbed and,
thus, decay slowly with depth [4]. The penetration depth of ultrasound in tissue is about 20 cm for
1 MHz [4].
Recently, a combination of therapy and diagnostics referred to as theragnostic has become very
popular [6,12]. Ultrasound waves are very often used in such therapies to diagnose, introduce a
targeted treatment, and simultaneously monitor the response to the therapy [6,12,16]. Moreover,
in order to ensure a proper temperature increase in the target area, often high-intensity focused
ultrasound (HIFU) procedures are combined with magnetic resonance imaging or ultrasound
imaging [3,14,17,18].
The requirement of high acoustic intensities in the thermal therapies such as FUS and HIFU often
leads to negative side effects such as skin burns, pain, or discomfort [2,17,19]. Extensive studies
have been performed to design and develop novel transducer technology and array designs to
achieve a rapid delivery of focused sonication [12]. Another possible strategy to achieve the
required temperatures without the use of high energies is to use additional materials, known
as sonosensitizers, which increase the ultrasound attenuation [20–24]; for example, magnetic
nanoparticles suspended in a carrier liquid. Magnetic nanoparticles in the form of ferrofluid
cause an additional increase in the temperature owing to the additional attenuation of the acoustic
wave [17,20,25,26]. Magnetic nanoparticles are good candidates to sonosensitizer the material
in ultrasound hyperthermia as they are biocompatible, nontoxic, biodegradable, and commonly
used in several medical applications [27,28]. Moreover, magnetic nanoparticles can be administered
intravenously or intra-arterially to the patient body. They can be directly injected into tumor area [29]
or delivered to the veins and then easily and precisely captured in the tumor area by an external
inhomogeneous magnetic field. It is possible to obtain good nanoparticle distribution throughout
tissues and organs [30]. The nanoparticles within the tumor area locally increase the attenuation
of the ultrasound wave; therefore, only this region is heated, while the surrounding healthy tissue
remains unaffected [31]. Simultaneously, owing to their susceptibility to the alternating magnetic
field, they become a source of heat in magnetic hyperthermia [25,26]. Thus, magnetic nanoparticles
can be applied as a material base for the use of synergetic effects of combined treatments (ultrasound
and magnetic hyperthermia), which often show much higher efficacy than single therapy strategies.
Recently, there has been a great interest in the application of multimodal hyperthermia, but according
to the authors’ knowledge, nobody has tried to combine magnetic and ultrasound hyperthermia yet.
However, to confirm and explain the reasons for these synergetic effects, it is necessary to conduct
more studies on the same tissue phantoms in comparable conditions with the use of ultrasound and
magnetic hyperthermia.
The aim of this study is to investigate the thermal effect of FUS hyperthermia enhanced by
magnetic nanoparticles as a function of the acoustic power and distance from the center of the
ultrasound focal zone. The specific absorption rate (SAR), which describes the rate of energy absorption
by the tissue exposed to ultrasound, was calculated and used for an additional data analysis. The SAR
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values were used to precisely describe and visualize the effectiveness of the hyperthermia in the focal
point and surrounding area.
2. Materials and Methods
2.1. Preparation and Characterization of Nanoparticles
In this study, magnetic nanoparticles were used as sonosensitizers, synthetized at the Institute
of Experimental Physics at the Slovak Academy of Science in Kosice, Slovakia, using an adapted
procedure originally proposed by Molday [32]. The magnetic core was covered with two layers of
surface active agents: sodium oleate and polyethylene glycol PEG 6000 to prevent agglomeration
and ensure material biocompatibility and nontoxicity [28,29]. The concentration of the magnetic
material in the prepared magnetic fluid was determined to be 23 mg/ml using ultraviolet–visible
(UV–VIS) spectrophotometry (Analytik Jena AG, Jena, Germany). The average size of the magnetic core
obtained from a magnetic measurement using a vibrating sample magnetometer (VSM, Cryogenic Ltd.,
London, UK) was 28 nm; however, the dominant part of the magnetization originated from particles
with a magnetic core size of 7 nm [33]. In order to provide further insights into the characteristics
of the nanomaterial, a transmission electron microscopy (TEM, JEOL Ltd., Tokyo, Japan) analysis
was performed. The obtained TEM image provides supplementary information about the size and
shape of individual nanoparticles. The TEM image in Figure 1 shows that the employed magnetic
fluid has a polydisperse size distribution. The size of the magnetic grain estimated from the TEM
measurement was 8 nm, which is in a good agreement with the nanoparticle size obtained from the
VSM measurement.
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Figure 1. (a) Transmission electron microscopy image; (b) Magnetic-particle size distribution. 
2.2. Preparation and Characterization of Phantoms 
The initial phase of many studies on ultrasound procedures on humans, including ultrasound 
hyperthermia, is performed on materials that mimic human tissues. Several tissue-mimicking 
materials such as polyvinyl alcohol, gelatin, or oil-based gel have speed of sound, attenuation, 
density, and acoustic impedance within the corresponding measured ranges of soft tissues [34]. In 
this study, we used tissue-mimicking materials made from agar powder, substance obtained from 
red algae. Agar forms a thermo-reversible gel in an aqueous solution; the gel remains stable over a 
wide temperature range. The agar-based gel has acoustic parameters (velocity of approximately 1540 
m/s, density of approximately 1.0 g/cm3, and attenuation of approximately 0.3–0.5 dB/cm·MHz) very 
similar to those of the human tissue [1,35]. 
For the hyperthermia measurements, we prepared two types of phantoms: pure agar gel 
phantoms without any added scattering material and agar gel phantoms with magnetic 
nanoparticles. The phantoms had a cylindrical shape with a diameter of 3 cm and height of 
approximately 3.5 cm. The weight concentration of agar in the phantoms ϕA was 5% (w/w), while the 
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2.2. Preparation and Characterization of Phantoms
The initial phase of many studies on ultrasound procedures on humans, including ultrasound
hyperthermia, is performed on materials that mimic human tiss es. Several tissue-mimicking
materials such as polyvinyl alcohol, gelatin, or oil-based gel have pe d of sound, attenuation, de sity,
and aco stic impedance within the corresponding measured ranges of soft tissues [34]. In this
study, we used issue-mimi king materials made from agar pow er, substance obtain d from red
algae. Agar forms a th r o-reversible g l in an queous solution; the gel rem i s stable over a wide
temperature range. The agar-based gel has acoustic parameters (velocity of approximately 1540 m/s,
nsity of approximately 1.0 g/cm3, and attenuation of pproximately 0.3–0.5 dB/c ·MHz) very
imilar to those of the human tissue [1,35].
F r the hyperthermia measurements, we prepared two types of phantoms: pure agar gel
phantoms without any added cattering mat rial and agar gel phantoms with magnetic nanoparticles.
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The phantoms had a cylindrical shape with a diameter of 3 cm and height of approximately 3.5 cm.
The weight concentration of agar in the phantoms φA was 5% (w/w), while the concentration of the
magnetic nanomaterial φM was 0.35% (w/w) (molar concentration: 0.0159 mol/L). The employed agar
powder was characterized by the company HiMedia as a standard plate count agar (Standard Methods
Agar M091-500G, Mumbai, India).
2.3. Electron Spin Resonance Studies
For a better understanding of the characteristics of the prepared nanomaterial and ultrasound
phantoms, electron spin resonance (ESR) studies were performed. ESR is an effective method to study
the properties and quality of magnetic nanoparticles as well as the impact of various conditions on
these properties [36–38]. The technique is based on the Zeeman phenomenon, in which a splitting
of the electron energy levels occurs in the sample, caused by the interaction of an external magnetic
field with magnetic moments of unpaired electrons. In order to observe the ESR signal, the resonance
condition has to be fulfilled:
hν = gµBB (1)
where g is the spectroscopic splitting factor, characteristic for each paramagnetic center, µB is the Bohr
magneton, B is the induction of the external magnetic field, and ν is the microwave frequency [39].
The ESR measurements were performed using an X-band (9.4 GHz) Bruker ESR/ENDOR EMX-10
spectrometer (BRUKER, Billerica, MA, USA) with a 100 kHz magnetic-field modulation. The ESR
spectra were acquired at room temperature for an amplitude modulation of 1 mT. The spectroscopic
parameters, g-factor (spectroscopic splitting factor) and peak-to-peak line width (∆H) with accuracies
of ±0.005 and ±0.5 mT, respectively, were determined for each ESR spectrum. An ESR spectrum for
the magnetic fluid is presented in Figure 2, while ESR spectra for the pure agar phantom and phantom
with nanoparticles are presented in Figure 3. The spectroscopic parameters determined using the ESR
spectra of the synthetized magnetic fluid, diluted magnetic fluid, and agar phantom with the same
concentration of nanoparticles are presented in Table 1.
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Table 1. Spectroscopic parameters determined from the ESR spectra of the studied samples.
Sample g-Factor± 0.005 ∆H ± 0.5 (mT)
Magnetic fluid 2.521 75.5
Magnetic fluid diluted in water (0.35% (w/w)) 2.437 79.1
Agar phantom – –
gar phantom with nanoparticles (0.35% (w/w)) 2.461 79.6
Figure 3 reveals that the pure agar phantom without magnetic material inside does not exhibit
magnetic properties; therefore, no ESR spectrum was observed. The ESR spectra for both magnetic
fluid (Figure 2) and magnetic nanoparticles in the phantom (Figure 3) are similar in shape; however,
their spectroscopic parameters are different (Table 1). The highest g-factor value is observed for the
original sample, while the lowest is observed for the nanoparticles diluted in water. For the line width
(∆H), the behavior is opposite, i.e., the line is the widest for the magnetic phantom with nanoparticles,
while the narrowest line is observed for the original sample. In a concentrated sample (magnetic
fluid), there are more nanoparticles in a given volume; therefore, they can aggregate and create larger
structures. In such situation, the exchange interactions between nanoparticles increase, manifested
by the narrowing of the ESR signal. Once the dilution nanoparticles are separated, the exchange
interactions decrease, the line width increases, and the g-factor decreases. This is observed in the
phantom where the magnetic nanoparticles are separated and their interactions are limited by the agar
gel. It can be assumed that the prepared phantoms have homogeneous structure and distribution of
nanoparticles. The spectroscopic parameters (Table 1) reveal that the employed magnetic fluid does
not contain only pure magnetite nanoparticles; it is likely that there is a mixture of different iron-oxide
nanoparticles such as magnetite and maghemite nanoparticles [33]. The shape of the ESR line and its
anisotropy are typical for nanoparticles in the size range of 5–15 nm, presented in Figure 1.
2.4. Measurement Setup
In-vitro hyperthermia experiments were performed on the tissue-mimicking phantoms using a
spherically focused single-element transducer fabricated by the Optel company. The measurement
setup consisted of an ultrasound phantom placed in a plastic beaker filled with distilled and
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degassed water at room temperature. The ultrasound head immersed in the water was coupled
to an ultrasound power generator, connected to a computer with a hyperthermia measurement
software. The temperature in the phantom during the FUS hyperthermia was measured using a
digital thermometer (Evolution FISO FPI-HR, FISO Technologies Inc., St-Jean-Baptiste, QC, Canada)
with an optical fiber sensor (model FOT-L-SD, FISO Technologies Inc., St-Jean-Baptiste, QC, Canada).
The optical fiber was centrally placed in the phantom at a height of approximately 0.5 cm below
the phantom surface. The thermometer was connected to a computer to record the experimental
data. The measurement setup is illustrated in Figure 4. The ultrasound transducer was driven in the
continuous-wave mode with an operating frequency of 1 MHz. The acoustic power of the transducer
was in the range of 2.7–10.3 W; the FUS hyperthermia results were obtained in this ultrasound power
range. In order to position the thermometer as close as possible to the focus of the ultrasound beam,
the phantom (containing the optical fiber) was mounted on a tri-axis positioning system (x, y, z).
After locating the focus point, hyperthermia measurements were performed as a function of the
acoustic power. In the experiments performed to evaluate the temperature as a function of the distance
from the focus point, after 15 s of hyperthermia treatment, the transducer was manually moved away
from the focus point by steps of 1 mm, first along the x-axis, and then along the y-axis. This enabled to
record the temperature increase in the area near the focal zone.
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suspended in gel-matrix results in more heat deposed into the phantom by ultrasound wave according
to the well-known relation P = 2µI, where P is the density of the heat power deposed in the phantom
by the ultrasound wave of the intensity I.
Measurements were repeated a minimum of 5 times and provided results represent the average
value of temperature increase. The experimental results of the temperature variations as a function of
the time for the pure agar phantom at different acoustic powers are presented in Figure 5. The increase
in the phantom temperature is caused by the attenuation of the ultrasound wave. A part of the
mechanical energy is lost owing to its conversion to heat. The temperature increases with the acoustic
power. A higher temperature increase is caused by attenuation of a larger amount of ultrasound energy.
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For the agar phantom with magnetic material, the temperature also increases with the acoustic
power. However, the agar phantom doped with sonosensitizers exhibits a higher temperature increase,
compared with the pure agar phantom for the same sonication time. The higher temperature increase
emerges owing to the additional attenuation of the scattering magnetic material.
Figure 7 shows the ultrasound-induced temperature variations with time for the pure agar
phantom and agar phantom with magnetic material for different acoustic powers. The temperature
increase in phantoms with and without magnetic nanoparticles were each compared using a paired
two-tailed t-test. A difference of the means with p < 0.05 was taken to be significant. For example,
the mean temperature differences between the phantoms with and without magnetic nanoparticles
were significant (p < 0.02) for 10.3 W of acoustic power and highly significant for 5.8 W and 2.7 W
(p < 0.000002 and p < 0.0000005, respectively). Thus, it can be concluded that the end-of-sonication
temperature for a magnetic-particle concentration of φM = 0.35% is higher than that for the phantom
containing only agar, for all acoustic powers.
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Figure 7. Temperature increase for a 5% concentration of pure agar gel and agar gel with
magnetic nanoparticles (φM = 0.35% (w/w)) for an ultrasou d frequency of 1 MHz for different
acoustic intensities.
This clearly demonstrates that magnetic nanoparticles are a good sonosensitizing material not
only for planar ultrasound hyperthermia [33] but also for FUS th rapy.
3.2. Heating by the FUS in an Area Distant from the Focal Point
In thermal therapies, it is crucial to increase the temperature in a specific area without affecting
the surrounding healthy tissues. Therefore, in HIFU treatments, the shape and size of the focal area, in
which the temperature is increased, are essential. In order to investigate the heat propagation in the
ultrasound phantom in the foc s area and effectiveness of t e ultrasounds in the center of the focus
region, additional experiments were performed. After positioning the thermometer as close as possible
to the center of the ultrasound beam, experiments were performed at an acoustic power of 4.4 W
to evaluate the temperature change as a function of the distance from the focus center. Figure 8a,b
present the results of the FUS hyperthermia as a function of the x-distance, while Figure 8c,d present
the results of the FUS hyperthermia as a function of the y-distance from the center of the focus point for
the pure agar phantom and that doped with sonosensitizers, respectively. Differences among means
are statistically significant (p < 0.05) by one-way ANOVA.
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Figure 8. Experimental temperature increase after 15 s of sonication as a function of the distance from
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The experimental results presented above clearly show that the temperature increase induced
by the FUS decreases with the increase of the distance from the center of the focus point. Moreover,
the temperature increase obtained for the phantom with magnetic material was higher than that for
the pure agar phantom. The most noticeable temperature increase was obtained in the center of the
focus area.
3.3. SAR
One of the most common methods to characterize the power deposition in the tissue during the
thermal treatment is to evaluate the SAR. The SAR value depends on the efficiency of the heat source
and the ability of the heated medium to absorb thermal energy. It means that in case of ultrasound
heating the SAR value depends on the ultrasound intensity in the focal zone and the coefficient
of ultrasound absorption of the heated region. The accurate determination of the SAR during the
FUS heating provides a physical basis to compare the temperatures obtained in the phantoms with
and without nanoparticles. According to the usual definition, the SAR describes the rate of energy
absorption by a tissue, calculated as [40]:
SAR = cp
(
dT
dt
)
t=0
(2)
where cp is the specific heat of the ultrasound phantom. In practice, obtaining SAR experimentally
involves measuring temperature increase following a step-in heating, fitting the resulting data to a
linear function in time, and then determining its slope at time zero. SAR may only be accurately
evaluated from initial slope of the temperature rise. This method does not take into account heat
Materials 2018, 11, 1607 10 of 15
conduction losses. This assumption may be valid if heat conduction losses are small compared to the
applied power. However, in FUS treatments with their small focal zones, it could be expected that heat
conduction might become important at very short times after heating is initiated, raising doubts about
the accuracy and practicality of the linear fit method.
Recently, a new analytical solution of the heat transfer equation for an improved SAR estimation
has been proposed by Dillon et al. [40]. Their analytical model assumes that the radial distribution of
the ultrasound power deposition pattern has a Gaussian shape:
Q = 2αI0 exp
(−r2
β
)
(3)
where the parameter β is a measure of the spread of the focal region. If the ratio of the axial to lateral
beam widths is larger than 2, one may assume that the spatial temperature gradient is dominated by the
radial conduction, and that the heat conduction in the axial direction can be neglected. According to
the Dillon’s analytical model, if off-axis experimental temperatures are measured as a function of time,
they could be used to directly estimate the SAR for the entire heating plane. The estimation of the SAR
values from these experimental data requires the off-axis analytical step-heating solution of the heat
transfer equation, i.e., for r 6= 0. It has the following form:
T(r, t) = C
(
β
4κ
)[
Ei
(−r2
β
)
− Ei
( −r2
β(1 + 4κt/β
)]
(4)
where C = 2αI0/ρcp and Ei represents the exponential integral. The acoustic pressure absorption
coefficient of the tissue is represented by α in the term C; I0 is the initial ultrasound intensity along the
beam axis, ρ is the tissue density, and cp is the specific heat of the tissue [41].
By a simultaneous fitting of all of the temperature–time data measured off-axis using Equation (4),
one can obtain single estimates for C, thermal diffusivity κ, and Gaussian variance β. The on- and
off-axis SAR values can then be calculated using:
SAR(r) = cpC· exp
(
r2
β
)
(5)
According to the data sheet of the transducer the lateral full width at half maximum (FWHM)
was assumed to be 0.9 mm which corresponds to the parameter β = 2.9× 10−7 m. In general β may
vary in case of inhomogeneous phantoms but because of the small concentration of sonosensitizing
nanoparticles (φM = 0.35%), it was assumed β to be the same for pure agar sample and agar with
magnetic nanoparticles. This left only two parameters C and κ to be fitted. From the least-squares fit
of experimental temperature-time data to the Equation (4) the thermal diffusivities of the pure agar
phantom and agar phantom with magnetic nanoparticles were estimated at (1.5± 0.1)× 10−7 m2 s−1
and (2.8± 0.2) × 10−7 m2 s−1, respectively. These values are in good agreement with our own
assessment [33].
Using the values of C and κ obtained from the best-fit procedure for the agar sample and agar
with magnetic nanoparticles, respectively. The addition of the magnetic material increases estimated
SAR value in the center of the focal zone (red area in Figure 9b) compared to that in pure agar sample.
Outside the center of the focal zone, the estimated SAR value rapidly goes away. Therefore, it can be
inferred that a tissue outside the focal zone will not be overheated.
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Table 2 presents the SAR values estimated for the center of the focal zone and at various radial
distances from it. For the pure agar phantom and agar phantom with magnetic nanoparticles,
the highest SAR values were obtained in the center of the ultrasonic beam. With the increase of
the distance from the center of the ultrasound focus, the SAR decreased.
Table 2. SAR values of the FUS hyperthermia along the radial direction from the center of the
focus zone.
Distance from
Focus (mm)
SAR for Pure
P antom (W/kg)
SAR for Phantom with
Son sensitizers (W/kg)
5 2 5
4 48 95
3 497 984
2 2631 5210
1 7153 14,162
0 9983 19,765
The global SAR values describing the overall power deposition in the tissue during the thermal
treatments for the pure agar phantom and agar phantom with sonosensitizers were calculated to be
9983 W/kg and 19765 W/kg, respectively. These results show that the addition of nanoparticles almost
doubles (increase of 98%) the global SAR, compared to that for the pure phantom. The increase in final
temperatures (after 15 s of heating) between both samples is less than increase in the SAR values (38%
vs. 98%). The reason for that is the thermal diffusivity which is about two times higher for the agar
phantom with nanoparticles compared to that for the pure agar sample. This results in faster heat
dissipation in case of phantom with magnetic nanoparticles.
3.4. Ultrasound Imaging
Ul rasounds can b used not only for therapy but ls for imaging and monitoring of the
ther peutic process and efficiency. Ultraso ography is one of th most common im ging methods
in clinical applications owing to its high sensitivity, broad acc ssibility, portability, and low cost.
Com nly used ultrasound contrast agents, microscale bubbles, are too large to extravasate from the
vascular lumen. The smaller- ize anoscale ag nt is advantag ous in this reg rd and diates their
accumulation at target sites [42]. The st died agar gel phantoms without a y added scattering
material and agar g l phantoms with agnetic nanoparticles were scanned with a diagnostic
ultrasound ima ing system (Sonoli e Prima, SIEMENS, Munich, Germany). The pure agar phantom
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was homogeneously hypoechoic owing to the lack of scattering (Figure 10a). The effect of the
scattering-material addition was manifested in the changes of the ultrasound wave parameters.
The values of the acoustic impedance Z = c·ρ (c: ultrasound velocity, ρ: density) also increased after
the addition of nanoparticles [43]. The phantoms with magnetic nanoparticles exhibited an increased
echogenicity owing to the significant number of scatters (Figure 10b) [44]. However small amount
of magnetic nanoparticles alone is a weak contrast agent to ultrasound imaging. Nanoparticles are
too small to backscatter ultrasound at a detectable level [45]. However, it is possible to use magnetic
properties of nanoparticles for molecular imaging by using the motion of these particles when subjected
to gradient magnetic field. Magnetic material placed in a nonuniform magnetic field, will rotate until
its magnetic moment is parallel to the field and translate toward the region with greater magnetic field
strength. The nanoparticles will be set in motion, and this movement (i.e., magnetomotive movement)
can be detected with ultrasound. Particle motion sensitizes ultrasound imaging systems [45–47].
It can be stated that the magnetic nanoparticles, which increase the therapeutic efficacy of the FUS
hyperthermia, can also influence the ultrasound contrast imaging (ultrasonography), and can act as
theranostic nanoparticles.
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4. Conclusions
The experimental results and numerical analysis showed that magnetic nanoparticles could
be employed as sonosensitizing materials in therapeutic FUS hyperthermia. Their presence in
tissue-mimicking phantoms changed the rate of heating. The addition of the nanoparticles increased
the global SAR almost two times compared to that for the pure phantom. The temperature increase
induced by the FUS and SAR evaluated from the experimental data decreased with the increase of
the distance from the center of the ultrasound focal zone. Therefore, the use of sonosensitizers in FUS
hyperthermia is advantageous as the temperature in the focal point sufficiently increases, while the
surrounding area is not overheated. In addition, the desired temperature increase in the focus can be
obtained in a shorter time, compared to pure FUS hyperthermia. Ultrasound imaging studies showed
that magnetic nanoparticles, in addition to their ability to increase the therapeutic efficacy of FUS
hyperthermia, can improve the contrast in ultrasonography. Therefore, magnetic nanoparticles are
very good candidates for ultrasound theranostic therapy.
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